Massachusetts Financial Services
LGND icon

Massachusetts Financial Services’s Ligand Pharmaceuticals LGND Stock Holding History

Massachusetts Financial Services’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.2M Sell
411,543
-95,476
-19% -$18.9M 0.03% 398
2025
Q4 		$95.9M Sell
507,019
-34,826
-6% -$6.69M 0.03% 387
2025
Q3 		$96M Buy
541,845
+202,103
+59% +$30M 0.03% 380
2025
Q2 		$38.6M Buy
339,742
+61,951
+22% +$6.62M 0.01% 522
2025
Q1 		$29.2M Buy
277,791
+1,060
+0.4% +$120K 0.01% 548
2024
Q4 		$29.7M Buy
+276,731
New +$31.3M 0.01% 547

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Massachusetts Financial Services's LGND Position: Q1 2026 in Review

Massachusetts Financial Services reduced its Ligand Pharmaceuticals (LGND) stake by 19% in Q1 2026, selling an estimated $18.9M and leaving 411,543 shares worth $82.2M. The position accounts for 0.03% of the portfolio, ranked #398.

Massachusetts Financial Services first reported a position in LGND in Q4 2024 and has held it in 6 quarters since. The position peaked at $96M in Q3 2025. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Massachusetts Financial Services held 411,543 shares of Ligand Pharmaceuticals worth $82.2M as of Q1 2026.
  • Massachusetts Financial Services sold 95,476 Ligand Pharmaceuticals shares in Q1 2026, an estimated $18.9M.
  • Ligand Pharmaceuticals made up 0.03% of Massachusetts Financial Services's portfolio in Q1 2026, its #398 holding.
  • Massachusetts Financial Services first reported a position in Ligand Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Massachusetts Financial Services's Ligand Pharmaceuticals position peaked at $96M in Q3 2025.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.